What does a reactive hepatitis B result with negative hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti‑HCV) < 0.1 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of Hepatitis B and C Test Results

Based on your description of "reactive for hepatitis B" with negative hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV) < 0.1, you most likely have a past hepatitis B infection that has resolved, indicated by isolated anti-HBc (hepatitis B core antibody) positivity.

Understanding Your Results

Your test results suggest the following pattern:

  • Reactive for hepatitis B = Anti-HBc positive (antibody to hepatitis B core antigen)
  • Negative HBsAg = No active hepatitis B surface antigen detected
  • Anti-HCV < 0.1 = No hepatitis C infection

What This Serological Pattern Means

The isolated anti-HBc positive pattern (HBsAg-negative/anti-HBc-positive) indicates one of several possibilities:

Most Likely Scenario: Resolved Past HBV Infection

  • Anti-HBc antibodies arise after any encounter with HBV and indicate past or current infection 1
  • In most cases, this represents a resolved infection where HBsAg has cleared
  • This pattern is common and typically benign in immunocompetent individuals

Less Common Scenarios to Consider:

1. Occult HBV Infection (Low-Level Viral Replication)

  • Some HBsAg-negative, anti-HBc-positive individuals may have continuing HBV replication at very low levels 2, 3
  • Studies show 14.4% of isolated anti-HBc individuals may be HBV DNA carriers with viral loads ranging from 800 to >4,000 copies/ml 3
  • However, this is primarily seen in patients with ongoing hepatic inflammation or liver disease 2

2. False-Negative HBsAg Results

  • Can occur due to variations in HBsAg epitopes not recognized by all assays 1
  • Different HBsAg tests use various antibodies with different capabilities to dissociate HBsAg from immune complexes 1
  • Rare but documented, particularly in certain clinical contexts 4

3. Window Period (Unlikely)

  • Brief period during acute infection when HBsAg has cleared but anti-HBs has not yet appeared
  • Would typically see elevated liver enzymes

Critical Next Steps

You need additional testing to clarify your infection status:

Essential Follow-Up Tests:

  1. Anti-HBs (hepatitis B surface antibody) - If positive (≥10 IU/L), confirms resolved infection with immunity 1, 5
  2. HBV DNA (viral load) - To rule out occult infection, especially if you have:
    • Elevated liver enzymes (ALT/AST)
    • Liver disease
    • Immunosuppression
    • Plans for immunosuppressive therapy 5

Risk Stratification Based on Additional Testing:

If anti-HBs is positive (≥10 IU/L):

  • Indicates resolved infection with protective immunity
  • No further action typically needed unless undergoing high-risk immunosuppression

If anti-HBs is negative and anti-HBc remains the only positive marker:

  • Consider HBV DNA testing to exclude occult infection 1, 3
  • This is particularly important if you have liver disease or will undergo immunosuppressive therapy 5

Important Clinical Implications

If You Require Immunosuppressive Therapy:

The 2025 AGA guidelines classify HBsAg-negative/anti-HBc-positive individuals as at risk for HBV reactivation (HBVr) 5:

  • High-risk therapies (e.g., B cell-depleting agents, CAR-T cell therapy): Antiviral prophylaxis recommended
  • Moderate-risk therapies (e.g., anti-TNF therapy, corticosteroids ≥4 weeks moderate/high dose): Consider prophylaxis
  • Low-risk therapies: Monitoring may be sufficient

Prophylaxis should start before immunosuppressive therapy and continue for at least 6 months after discontinuation (12 months for B cell-depleting agents) 5

Monitoring Considerations:

If you are anti-HBc-positive alone (without anti-HBs), you require monitoring and/or preventive measures before immunosuppression, as these individuals may have ongoing infection despite negative HBsAg 1

Common Pitfalls to Avoid

  1. Don't assume isolated anti-HBc always means benign resolved infection - Occult infection occurs in 14.4% of cases 3
  2. Don't rely on a single HBsAg assay - False negatives can occur; anti-HBc and HBV DNA testing are reliable methods to resolve discrepancies 1, 4
  3. Don't skip anti-HBs testing - This is critical to distinguish resolved infection with immunity from isolated anti-HBc positivity 1
  4. Don't ignore this pattern if immunosuppression is planned - HBV reactivation can be severe and potentially fatal 5

Bottom Line

Your results most likely indicate past hepatitis B infection that has resolved. However, you must obtain anti-HBs testing to confirm immunity, and consider HBV DNA testing if you have liver disease, elevated liver enzymes, or plans for immunosuppressive therapy. The hepatitis C result is clearly negative and requires no further action.

Related Questions

Which hepatitis B serology tests should be ordered to assess vaccination status, past exposure, acute infection, or chronic carrier state?
What is the appropriate management for a patient with negative hepatitis B surface antigen (HBsAg), reactive hepatitis B surface antibody (anti‑HBs), positive total hepatitis B core antibody (anti‑HBc total), negative IgM hepatitis B core antibody (IgM anti‑HBc), reactive hepatitis C antibody (anti‑HCV) and hepatitis C RNA approximately 10 million IU/mL (log10 7.0)?
What does a reactive total anti‑HBc antibody with negative anti‑HBc IgM and negative HBsAg indicate?
What is the hepatitis B status for a patient with hepatitis B surface antibody positive, hepatitis B surface antigen negative, total hepatitis B core antibody positive, and hepatitis B core IgM antibody negative?
A 55-year-old male with chronic hepatitis B on tenofovir alafenamide (Vemlidy) for four years now has undetectable HBV DNA but remains hepatitis B surface antigen (HBsAg) positive and hepatitis B surface antibody (anti‑HBs) negative; what management is recommended?
What are the best treatment options for a 22‑month‑old male with a two‑week history of significant upper respiratory congestion and nocturnal coughing fits that cause vomiting?
Can Naftopidil (α‑1 blocker for benign prostatic hyperplasia) and Bethanechol (cholinergic agonist for bladder stimulation) be used together safely, and what dosing adjustments or monitoring are required?
Should a dog that had a surgical incision 48 hours ago and just licked the incision receive prophylactic antibiotics, given that the surgical site appears normal?
In a 22‑month‑old with one week of upper‑respiratory congestion, nocturnal cough with post‑tussive vomiting, no fever, ear or sinus pain, and no focal lung findings, should antibiotics be prescribed?
In a 22‑month‑old child with a viral upper respiratory infection, should antibiotics be started after 10 days of symptoms?
What is the recommended evaluation and treatment for low ionized calcium?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.